Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „inducer“
Suchtreffer
Begriffe & Kennungen
Clopidogrel Krka · 4.5 · Other concomitant therapy: Inducers of CYP2C19 Since clopidogrel is metabolised to its active metabolite partl
Eintrag öffnenClopidogrel TAD · 4.5 · Other concomitant therapy: Inducers of CYP2C19 Since clopidogrel is metabolised to its active metabolite partl
Eintrag öffnenClopidogrel Taw Pharma (previously Clopidogrel Mylan) · 4.5 · Inducers of CYP2C19 Since clopidogrel is metabolised to its active metabolite partly by CYP2C19, use of medici
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · Inducers of CYP2C19 Since clopidogrel is metabolised to its active metabolite partly by CYP2C19, use of medici
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.5 · Inducers of CYP2C19: Since clopidogrel is metabolised to its active metabolite partly by CYP2C19, use of medic
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Other concomitant therapy Inducers of CYP2C19 Since clopidogrel is metabolised to its active metabolite partly
Eintrag öffnenCombivir · 4.5 · Zidovudine is primarily metabolised by UGT enzymes; co-administration of inducers or inhibitors of UGT enzymes
Eintrag öffnenCopalia · 4.5 · CYP3A4 inducers (anticonvulsant agents [e.g. carbamazepine, phenobarbital, phenytoin, fosphenytoin, primidone]
Eintrag öffnenCorlentor · 4.5 · CYP3A4 inducers
Eintrag öffnenCorlentor · 4.5 · CYP3A4 inducers (e.g. rifampicin, barbiturates, phenytoin, Hypericum perforatum [St John’s Wort]) may decrease
Eintrag öffnenCotellic · 4.5 · CYP3A inducers
Eintrag öffnenCotellic · 4.5 · Co-administration of cobimetinib with a strong CYP3A inducer was not assessed in a clinical study, however, a
Eintrag öffnenCotellic · 4.5 · In vitro, cobimetinib is a potential inducer of CYP1A2 and may therefore reduce the exposure of substrates of
Eintrag öffnenCresemba · 4.3 · Co-administration with strong CYP3A4/5 inducers such as rifampicin, rifabutin, carbamazepine, long- acting bar
Eintrag öffnenCresemba · 4.3 · Co-administration with strong CYP3A4/5 inducers such as rifampicin, rifabutin, carbamazepine, long- acting bar
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Efavirenz Not studied. The concomitant administration (CYP3A4/5 moderate inducer Efaviren
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Efavirenz Not studied. The concomitant administration (CYP3A4/5 moderate inducer Efaviren
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Etravirine Not studied. The concomitant administration (moderate CYP3A4/5 inducer) Isavuc
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Etravirine Not studied. The concomitant administration (moderate CYP3A4/5 inducer) Isavuc
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Nafcillin Not studied. The concomitant administration (moderate CY3A4/5 inducer) Isavucon
Eintrag öffnen